Stock Detail
GENETIC TECHNOLOGIES LTD - AMERICAN DEPOSITARY SHARES REPRESENTING 30 ORDINARY SHARES
Sector: Biotechnology
Latest Quote @ Mon May 5 02:16:10 (15 min delayed)
| N/A |
N/A |
$2.85 |
+0.17 |
6.34% |
|
Last Day's Data
| $2.85 |
$2.98 |
$0.17 |
6.34% |
0.00 |
$2.68 |
| $2.67 |
$2.60 |
161,470.00 |
44.45M |
59,995.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 3.19 |
3.02 |
2.81 |
2.64 |
2.43 |
Stock Profile
Genetic Technologies Limited operates as a life science company specializing in genetics and genomics. The company owns and out-licenses a series of patents covering the use of ‘non-coding' DNA. It also offers a range of genetic testing services covering humans, animals, and plants. The company's services comprise human diagnostics, including testing of predisposition to disease, profiling, and forensic, as well as personalized diagnostics; animal diagnostics services that include tests for parentage, predisposition to diseases, traits, and the maintenance of stud books; and plant DNA testing services that primarily include high throughput extraction of plasmid, high throughput DNA sequencing, high throughput genotyping, marker discovery, and high volume variety identification for plants. It also engages in the research and development in the areas of genetics and related fields. The company was incorporated in 1987 as Concord Mining N.L. and changed its name to Duketon Goldfields N.L. in 1995. Later, it changed its name to Genetic Technologies Limited in 2000. The company is based in Fitzroy, Australia.
